Literature DB >> 6402761

Factors involved in the initiation of phage phi 29 DNA replication in vitro: requirement of the gene 2 product for the formation of the protein p3-dAMP complex.

L Blanco, J A Garcìa, M A Peñalva, M Salas.   

Abstract

To study the requirements for the in vitro formation of the protein p3-dAMP complex, the first step in phi29 DNA replication, extracts from B. subtilis infected with phi29 mutants in genes 2, 3, 5, 6 and 17, involved in DNA synthesis, have been used. The formation of the initiation complex is completely dependent on the presence of a functional gene 2 product, in addition to protein p3 and phi29 DNA-protein p3 as template. ATP is also required, although it can be replaced by other nucleotides. The products of genes 5, 6 and 17 do not seem to be needed in the formation of the initiation complex. Inhibitors of the host DNA polymerase III, DNA gyrase or RNA polymerase had no effect on the formation of the protein p3-dAMP complex, suggesting that these proteins are not involved in the initiation of phi29 DNA replication. ddATP or aphidicolin, inhibitors of DNA chain elongation, had also no effect on the formation of the initiation complex.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6402761      PMCID: PMC325798          DOI: 10.1093/nar/11.5.1309

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  41 in total

1.  Adenovirus DNA replication in vitro: identification of a host factor that stimulates synthesis of the preterminal protein-dCMP complex.

Authors:  K Nagata; R A Guggenheimer; T Enomoto; J H Lichy; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

2.  Separation of the adenovirus terminal protein precursor from its associated DNA polymerase: role of both proteins in the initiation of adenovirus DNA replication.

Authors:  J H Lichy; J Field; M S Horwitz; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

3.  Structure of protein-containing replicative intermediates of Bacillus subtilis phage phi 29 DNA.

Authors:  J M Sogo; J A García; M A Peñalva; M Salas
Journal:  Virology       Date:  1982-01-15       Impact factor: 3.616

4.  In vitro complex formation between bacteriophage phi 29 terminal protein and deoxynucleotide.

Authors:  M Shih; K Watabe; J Ito
Journal:  Biochem Biophys Res Commun       Date:  1982-04-14       Impact factor: 3.575

5.  Nucleotide sequence of the major early region of bacteriophage phi 29.

Authors:  H Yoshikawa; J Ito
Journal:  Gene       Date:  1982-03       Impact factor: 3.688

6.  Initiation of phage phi 29 DNA replication in vitro: formation of a covalent complex between the terminal protein, p3, and 5'-dAMP.

Authors:  M A Peñalva; M Salas
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

7.  Function of adenovirus terminal protein in the initiation of DNA replication.

Authors:  F Tamanoi; B W Stillman
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

8.  Nucleotide sequence of the early genes 3 and 4 of bacteriophage phi 29.

Authors:  C Escarmís; M Salas
Journal:  Nucleic Acids Res       Date:  1982-10-11       Impact factor: 16.971

9.  High level synthesis in Escherichia coli of the Bacillus subtilis phage phi 29 proteins p3 and p4 under the control of phage lambda PL promoter.

Authors:  R P Mellado; M Salas
Journal:  Nucleic Acids Res       Date:  1982-10-11       Impact factor: 16.971

10.  Initiation of adenovirus DNA replication: detection of covalent complexes between nucleotide and the 80-kilodalton terminal protein.

Authors:  M D Challberg; J M Ostrove; T J Kelly
Journal:  J Virol       Date:  1982-01       Impact factor: 5.103

View more
  11 in total

1.  Characterization of a 3'----5' exonuclease activity in the phage phi 29-encoded DNA polymerase.

Authors:  L Blanco; M Salas
Journal:  Nucleic Acids Res       Date:  1985-02-25       Impact factor: 16.971

2.  Overproduction and purification of protein P6 of Bacillus subtilis phage phi 29: role in the initiation of DNA replication.

Authors:  R Pastrana; J M Lázaro; L Blanco; J A García; E Méndez; M Salas
Journal:  Nucleic Acids Res       Date:  1985-05-10       Impact factor: 16.971

3.  Bacteriophage phi 29 DNA replication in vitro: participation of the terminal protein and the gene 2 product in elongation.

Authors:  K Matsumoto; T Saito; C I Kim; T Ando; H Hirokawa
Journal:  Mol Gen Genet       Date:  1984

4.  Initiation of phage phi 29 DNA replication by the terminal protein modified at the carboxyl end.

Authors:  R P Mellado; M Salas
Journal:  Nucleic Acids Res       Date:  1983-11-11       Impact factor: 16.971

5.  Purification in a functional form of the terminal protein of Bacillus subtilis phage phi 29.

Authors:  I Prieto; J M Lázaro; J A García; J M Hermoso; M Salas
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

6.  A novel DNA polymerase induced by Bacillus subtilis phage phi 29.

Authors:  K Watabe; J Ito
Journal:  Nucleic Acids Res       Date:  1983-12-10       Impact factor: 16.971

7.  Characterization and purification of a phage phi 29-encoded DNA polymerase required for the initiation of replication.

Authors:  L Blanco; M Salas
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

8.  Replication of bacteriophage phi 29 DNA in vitro: the roles of terminal protein and DNA polymerase.

Authors:  K Watabe; M Leusch; J Ito
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

9.  Template requirements for initiation of phage phi 29 DNA replication in vitro.

Authors:  J A García; M A Peñalva; L Blanco; M Salas
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

10.  Replication of phage phi 29 DNA with purified terminal protein and DNA polymerase: synthesis of full-length phi 29 DNA.

Authors:  L Blanco; M Salas
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.